Franklin Resources’s Meridian Bioscience Inc VIVO Stock Holding History

Franklin Resources’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-14,553	Closed	-$483K	–	2430
2022 Q4	$483K	Sell	14,553 -108	-0.7%	-$3.48K	﹤0.01%	1706
2022 Q3	$462K	Buy	14,661 +133	+0.9%	+$4.31K	﹤0.01%	1709
2022 Q2	$441K	Sell	14,528 -3,796	-21%	-$103K	﹤0.01%	1742
2022 Q1	$475K	Buy	18,324 +486	+3%	+$11.6K	﹤0.01%	1849
2021 Q4	$364K	Sell	17,838 -599	-3%	-$11.5K	﹤0.01%	2021
2021 Q3	$355K	Buy	+18,437	New	+$368K	﹤0.01%	2023

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Franklin Resources's VIVO Position: Q1 2023 in Review

Franklin Resources sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 14,553 shares — an estimated $483K sold.

Franklin Resources first reported a position in VIVO in Q3 2021 and held it in 6 quarters. The position peaked at $483K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Franklin Resources reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Franklin Resources sold 14,553 Meridian Bioscience Inc shares in Q1 2023, an estimated $483K.
Franklin Resources first reported a position in Meridian Bioscience Inc in Q3 2021 and held it in 6 quarters.
Franklin Resources's Meridian Bioscience Inc position peaked at $483K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Franklin Resources's 13F filing for Q1 2023, filed 12 May 2023.